PRESS RELEASE published on 12/05/2024 at 09:30, 1 year 3 months ago Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments Eckert & Ziegler and Ariceum Therapeutics sign global supply agreement for developing next-generation radiotherapeutics. Collaboration to accelerate targeted cancer treatments Eckert & Ziegler Ariceum Therapeutics Global Supply Agreement Radiotherapeutics Precision Cancer Treatments
BRIEF published on 12/03/2024 at 14:34, 1 year 3 months ago Eckert & Ziegler Announces Executive and Supervisory Board Changes Executive Board Supervisory Board Eckert & Ziegler Dr. Gunnar Mann Jutta Ludwig
BRIEF published on 12/03/2024 at 14:34, 1 year 3 months ago Eckert & Ziegler annonce des changements au sein de son conseil d'administration et de son conseil de surveillance Eckert & Ziegler Conseil De Surveillance Conseil Exécutif Jutta Ludwig Dr Gunnar Mann
PRESS RELEASE published on 12/03/2024 at 14:29, 1 year 3 months ago Eckert & Ziegler: Changes in the Executive Board and Supervisory Board Eckert & Ziegler SE appoints Dr. Gunnar Mann to Executive Board and welcomes changes in Supervisory Board. Dr. Mann to lead Medical segment Executive Board Supervisory Board Eckert & Ziegler SE Medical Segment Dr. Gunnar Mann
BRIEF published on 12/02/2024 at 09:05, 1 year 3 months ago Eckert & Ziegler Initiates Actinium-225 Production to Tackle Global Shortage Nuclear Medicine Radiopharmaceuticals Actinium-225 Production Isotope Supply GMP Certification
BRIEF published on 12/02/2024 at 09:05, 1 year 3 months ago Eckert & Ziegler lance la production d'actinium 225 pour faire face à la pénurie mondiale Produits Radiopharmaceutiques Médecine Nucléaire Production D'actinium 225 Approvisionnement En Isotopes Certification GMP
PRESS RELEASE published on 12/02/2024 at 09:00, 1 year 3 months ago Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply Eckert & Ziegler starts Actinium-225 production in collaboration with Czech Academy of Sciences, aiming for GMP-grade supply to boost alpha-emitting radiopharmaceuticals development Eckert & Ziegler Production Radiopharmaceuticals Actinium-225 GMP-grade
BRIEF published on 11/27/2024 at 09:05, 1 year 3 months ago Eckert & Ziegler Gains European Approval for Theralugand® Cancer Therapy Radiopharmaceuticals Lutetium-177 European Approval Theralugand®
BRIEF published on 11/27/2024 at 09:05, 1 year 3 months ago Eckert & Ziegler obtient l'approbation européenne pour Theralugand® Produits Radiopharmaceutiques Thérapie Contre Le Cancer Lutetium-177 Theralugand® Agrément Européen
PRESS RELEASE published on 11/27/2024 at 09:00, 1 year 3 months ago Eckert & Ziegler Achieves European Approval for Theralugand® - Lutetium-177 Chloride (n.c.a) Eckert & Ziegler receives EC approval for Theralugand® - Lutetium-177 Chloride, expanding cancer therapy options in Europe Eckert & Ziegler Cancer Therapy EC Approval Theralugand Lutetium-177 Chloride
Published on 03/23/2026 at 08:00, 58 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 6 hours 58 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 08:30, 28 minutes ago Cyberclick and HubSpot Bring Together London Business Leaders to Explore the Next Phase of AI-driven CRM
Published on 03/23/2026 at 08:26, 31 minutes ago Staking Rush in Ontario: Storm Exploration Secures the Prime Plots in the New Gold Belt
Published on 03/23/2026 at 08:20, 38 minutes ago Eurobattery Minerals becomes debt-free as the final convertible bonds are fully converted into shares
Published on 03/23/2026 at 08:00, 58 minutes ago Zentra Group plc: Unaudited interim report for the six months ended 31 December 2025
Published on 03/23/2026 at 08:10, 48 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 13 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 13 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 14 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 14 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
